Glucopath
Device Pump

Sequel twiist AID System

Who it is for

Newest AID system (launched July 2025); pharmacy-dispensed; FDA-cleared for T1D

What it covers

Free first month trial; projected ≤$50/month thereafter; dispensed like a prescription

What it costs you

Rough estimate of annual insulin pump supply cost avoided, not device cost, not program-specific.

Eligibility

  • Newest AID system (launched July 2025); pharmacy-dispensed; FDA-cleared for T1D
  • Insurance status: private, marketplace
  • Diabetes type: T1D
  • U.S. residency or citizenship documentation required
  • Available in: all

What you will need to apply

Use our universal document checklist.

Official links

Glucopath is not medical or legal advice. Program rules change. Verify details with the program before you apply, and talk to your healthcare provider about your treatment.